Management of health-care workers exposed to blood and body fluids
Related Experiment Videos
Today'S OR Nurse
|October 1, 1991
Abstract:
1. The risk of transmission of HIV from an infected patient to a percutaneously exposed HCW is about 1 in 200 to 300. 2. The exposure, the source patient and the HCW recipient must be assessed to determine the risk of HIV infection to the recipient. 3. Azidothymidine (AZT, zidovudine) is the only drug currently licensed by the FDA for the treatment of HIV infection.